logo
We Ran A Stock Scan For Earnings Growth And Tower (NZSE:TWR) Passed With Ease

We Ran A Stock Scan For Earnings Growth And Tower (NZSE:TWR) Passed With Ease

Yahoo5 days ago

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. Unfortunately, these high risk investments often have little probability of ever paying off, and many investors pay a price to learn their lesson. Loss making companies can act like a sponge for capital - so investors should be cautious that they're not throwing good money after bad.
So if this idea of high risk and high reward doesn't suit, you might be more interested in profitable, growing companies, like Tower (NZSE:TWR). While profit isn't the sole metric that should be considered when investing, it's worth recognising businesses that can consistently produce it.
We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
In the last three years Tower's earnings per share took off; so much so that it's a bit disingenuous to use these figures to try and deduce long term estimates. As a result, we'll zoom in on growth over the last year, instead. Outstandingly, Tower's EPS shot from NZ$0.10 to NZ$0.26, over the last year. It's not often a company can achieve year-on-year growth of 152%.
One way to double-check a company's growth is to look at how its revenue, and earnings before interest and tax (EBIT) margins are changing. The good news is that Tower is growing revenues, and EBIT margins improved by 10.8 percentage points to 21%, over the last year. That's great to see, on both counts.
In the chart below, you can see how the company has grown earnings and revenue, over time. For finer detail, click on the image.
Check out our latest analysis for Tower
Of course the knack is to find stocks that have their best days in the future, not in the past. You could base your opinion on past performance, of course, but you may also want to check this interactive graph of professional analyst EPS forecasts for Tower.
Insider interest in a company always sparks a bit of intrigue and many investors are on the lookout for companies where insiders are putting their money where their mouth is. This view is based on the possibility that stock purchases signal bullishness on behalf of the buyer. Of course, we can never be sure what insiders are thinking, we can only judge their actions.
The first bit of good news is that no Tower insiders reported share sales in the last twelve months. Even better, though, is that the company insider, Blair Turnbull, bought a whopping NZ$429k worth of shares, paying about NZ$1.48 per share, on average. Big buys like that may signal an opportunity; actions speak louder than words.
Tower's earnings have taken off in quite an impressive fashion. Most growth-seeking investors will find it hard to ignore that sort of explosive EPS growth. And may very well signal a significant inflection point for the business. If this is the case, then keeping a watch over Tower could be in your best interest. We should say that we've discovered 2 warning signs for Tower (1 makes us a bit uncomfortable!) that you should be aware of before investing here.
There are plenty of other companies that have insiders buying up shares. So if you like the sound of Tower, you'll probably love this curated collection of companies in NZ that have an attractive valuation alongside insider buying in the last three months.
Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Aurora Cannabis says ‘second instance of misinformation' posted on Investing.com
Aurora Cannabis says ‘second instance of misinformation' posted on Investing.com

Yahoo

time10 hours ago

  • Yahoo

Aurora Cannabis says ‘second instance of misinformation' posted on Investing.com

Aurora Cannabis (ACB) announced that it has become aware of 'a second instance of misinformation' posted on news website On June 18, Aurora advised the market that an article posted on incorrectly stated that Aurora had agreed to acquire New Zealand-based MedLeaf Therapeutics. Later in the day on June 18, a second article was posted on that incorrectly states that Aurora has entered into a strategic partnership with MediPharm GmbH for distribution of medical cannabis in Germany and other EU markets. 'The company categorically denies both articles. Aurora has not entered into any such agreements, has had no discussions with MedLeaf Therapeutics or MediPharm GmbH with respect to any business combination transaction or strategic partnership, and has not made any statements or filed any information pertaining to any such transactions. The erroneous articles posted on state that they were generated 'with the support of AI' and reviewed by an editor. The company is launching an investigation into the genesis of these articles. In the meantime, Aurora confirms that it is not in possession of material non-public information and advises investors that should not be considered a credible source of information regarding the company. Any information regarding material corporate transactions will be announced directly by the company to the market as soon as it is appropriate to do so,' Aurora stated. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on ACB: Disclaimer & DisclosureReport an Issue Aurora Cannabis Reports Record Revenue and Growth Aurora Cannabis Denies Acquisition Rumors of MedLeaf Therapeutics Aurora Cannabis denies acquisition of MedLeaf Therapeutics Morning Movers: Circle rises following regulatory framework for stablecoins Aurora Cannabis Achieves Record Revenue and EBITDA in Fiscal 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

New Zealand PM Luxon meets China's Xi Jinping
New Zealand PM Luxon meets China's Xi Jinping

Yahoo

time16 hours ago

  • Yahoo

New Zealand PM Luxon meets China's Xi Jinping

(Reuters) -New Zealand Prime Minister Christopher Luxon said on Friday he and China's President Xi Jinping discussed the role of business, education and science to help boost relations between the two countries. "I raised the importance to New Zealand of the international rules-based system, as well as the key role that China can play in helping to resolve global challenges," Luxon said in a statement after meeting Xi Jinping in Beijing.

New Zealand Prime Minister Luxon talks trade in meeting with China's Xi
New Zealand Prime Minister Luxon talks trade in meeting with China's Xi

Yahoo

time16 hours ago

  • Yahoo

New Zealand Prime Minister Luxon talks trade in meeting with China's Xi

BEIJING (AP) — The prime minister of New Zealand stressed the importance of his country's trade ties with China in a meeting with Chinese leader Xi Jinping on Friday. Christopher Luxon, on his first visit to China since becoming prime minister in late 2023, flew to Beijing after two days of meetings with officials and business leaders in Shanghai, China's commercial center. He wants to maintain healthy trade relations with China, an important market for New Zealand products, despite differences over regional and global security issues and China's growing divide with the United States. 'Our trade and economic links are complementary and contribute to prosperity in both countries,' he was quoted as saying in a news release following his meeting with Xi. Luxon said he raised the necessity of reducing tensions in the Indo-Pacific region and the importance of what he called 'the key role' that China can play in helping to resolve global challenges such as the war in Ukraine. 'In a complex world, open dialogue is more important than ever,' Luxon said in a post about the meeting on X. His exchange with Xi came one day after revelations that New Zealand had suspended millions of dollars in aid to the Cook Islands over concerns about the latter's deepening ties with China. China accounts for more than 20% of New Zealand's exports of goods and services.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store